Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Klotho Neurosciences, Inc. - Warrants
No Price
28.04.2026 20:00
Current Prices from Klotho Neurosciences, Inc. - Warrants
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
GRMLW
USD
28.04.2026 20:00
0,19 USD
-0,04 USD
-15,80 %
IEX
GRMLW
USD
24.04.2026 19:27
0,19 USD
-
Share Float & Liquidity
Free Float90,76 %
Shares Float65,79 M
Shares Outstanding72,49 M
Company Profile for Klotho Neurosciences, Inc. - Warrants Share
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
